ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock Cash Flow
NASDAQ:ASBP - Nasdaq - US7389201077 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
| Net Income | -12.54M | 4.46M | 3.34M | |||
| Change In Working Capital | 1.03M | 687.10K | -430.00K | |||
| Other non cash items | 9.45M | -5.80M | -4.32M | |||
| OPERATING CASH FLOW | -2.05M | -653.10K | -1.41M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
| Other Investing Activity | 13.78M | 284.92M | -294.69M | |||
| INVESTING CASH FLOW | 13.78M | 284.92M | -294.69M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
| Debt Issued/Reduced | 2.05M | 155.80K | -250.00K | |||
| Stock Issued/Repurchased | -13.78M | -284.92M | N/A | |||
| Other Financing Activity | N/A | 0.00 | 296.85M | |||
| FINANCING CASH FLOW | -11.73M | -284.76M | 296.59M | |||
| CHANGE IN CASH | 0.00 | -497.30K | 490.00K | |||
| FREE CASH FLOW | ||||||
| Operating Cash Flow | -2.05M | -653.10K | -1.41M | |||
| FREE CASH FLOW | -2.05M | -653.10K | -1.41M | |||
All data in USD